Hypermutation in natural bacterial populations: Consequences for medical microbiology

Reviews and Research in Medical Microbiology

Volumn 16, Issue 1, 2005, Pages 25-32

  Oliver, Antonio ^a  

^a HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

Author keywords

Antibiotic resistance; Bacterial adaptation mechanisms; Bacterial evolution; Hypermutation; Mutator

Indexed keywords

ADAPTIVE BEHAVIOR; ANTIBIOTIC RESISTANCE; BACTERIAL MUTATION; BACTERIAL STRAIN; BACTERIUM COLONY; CHRONIC LUNG DISEASE; CYSTIC FIBROSIS; DNA REPAIR; EPIDEMIC; EVOLUTION; GENETICS; HAEMOPHILUS INFLUENZAE; HUMAN; NEISSERIA MENINGITIDIS; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; REVIEW; STAPHYLOCOCCUS AUREUS; STRESS;

EID: 15044353144     PISSN: 0954139X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00013542-200501000-00004     Document Type: Review

References (63)

1. Radman M, Taddei F, Matic I. Evolution driving genes. Res Microbiol 2000; 151:91-95.
2. Miller JH. Spontaneous mutators in bacteria: insights into pathways of mutagenesis and repair. Annu Rev Microbiol 1996; 50:625-643.
3. Modrich P, Lahue R. Mismatch repair in replication fidelity, genetic recombination, and cancer biology. Annu Rev Biochem 1996; 65:101-133.
4. Horst JP, Wu TH, Marinus MG. Escherichia coli mutator genes. Trends Microbiol 1999; 7:29-36.
5. Leach FS, Nicolaides NC, Papadopoulos N, Liu B, Jen J, Parsons R, et al. Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell 1993; 75:1215-1225.
6. Matic I, Rayssiguer C, Radman M. Interspecies gene exchange in bacteria: The role of SOS and mismatch repair systems in evolution of species. Cell 1995; 80:507-515.
7. Friedberg EC, Wagner R, Radman M. Specialized DNA polymerises, cellular survival, and the genesis of mutations. Science 2002; 296:1627-1630.
8. Blázquez J, Oliver A, Gómez-Gómez JM. Mutation and evolution of antibiotic resistance: antibiotics as promoters of antibiotic resistance? Curr Drug Targets 2002; 3:345-349.
9. Gibson TC, Scheppe ML, Cox EC. Fitness of an Escherichia coli mutator gene. Science 1970; 169:686-688.
10. Cox EC, Gibson TC. Selection for high mutation rates in chemostats. Genetics 1974; 77:169-184.
11. Sniegowski PD, Gerrish PJ, Lenski RE. Evolution of high mutation rates in experimental populations of E. coli. Nature 1997; 387:703-705.
12. Taddei F, Radman M, Maynard-Smith J, Toupance B, Gouyon PH, Godellete B. Role of imitator alleles in adaptive evolution. Nature 1997; 387:700-702.
13. Mao EF, Lane L, Lee J, Miller JH. Proliferation of mutators in a cell population. J Bacteriol 1997; 179:417-422.
14. Funchain P, Yeung A, Stewart J, Clendenin WM, Miller JH. Amplification of mutator cells in a population as a result of horizontal transfer. J Bacteriol 2001; 183:3737-3741.
15. Giraud A, Matic I, Tenaillon O, Clara A, Radman M, Fons M, et al. Cost and benfits of high mutation rates: adaptive evolution of bacteria in the mouse gut. Science 2001; 291:2606-2608.
16. LeClerc JE, Li B, Payne WL, Cebula TA. High mutation frequencies among Escherichia coli and Salmonella pathogens. Science 1996; 274:1208-1211.
17. Matic I, Radman M, Taddei F, Picard B, Doit C, Bingen E, et al. High variable mutation rates in commensal and pathogenic Escherichia coli. Science 1997; 277:1833-1834.
18. Oliver A, Cantón R, Campo P, Baquero F, Blázquez J. High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. Science 2000; 288:1251-1253.
19. Prunier AL, Malbruny B, Laurans M, Brouard J, Duhamel JF, Leclerc R. High rate of macrolide resistance in Staphylococcus aureus strains from patients with cystic fibrosis reveals high proportions of hypermutable strains. J Infect Dis 2003; 187:1709-1716.
20. Román F, Cantón R, Pérez-Vazquez M, Baquero F, Campos F. Dynamics of long-term colonization of respiratory tract by Haemophilus influenzae in cystic fibrosis patients shows a marked increase in hypermutable strains. J Clin Microbiol 2004; 42:1450-1459.
21. Watson ME, Burns JL, Smith AL. Hypermutable Haemophilus influenzae with mutations in mutS are found in cystic fibrosis sputum. Microbiology 2004; 150:2947-2958.
22. Bjorkholm B, Sjolund M, Falk PG, Berg OG, Engstrand L, Andersson DI. Mutation frequency and biological cost of antibiotic resistance in Helicobacter pylori. Proc Natl Acad Sci USA 2001; 98:14607-14612.
23. Richardson AR, Stojiljkovic I. Mismatch repair and the regulation of phase variation in Neisseria meningitidis. Mol Microbiol 2001; 40:645-655.
24. Morosini MI, Baquero MR, Sanchez-Romero JM, Negri MC, Galan JC, del Campo R, et al. Frequency of mutation to rifampicin resistance in Streptococcus pneumoniae clinical strains: hexA and hexB polymorphims do not account for hypermutation. Antimicrob Agents Chemother 2003; 47:1464-1467.
25. De Champs C, Rich C, Chandezon P, Chanal C, Sirot D, Forestier C. Factors associated with antimicrobial resistance among clinical isolates of Klebsiella pneumoniae: 1-year survey in a French university hospital. Eur J Clin Microbiol lnfec Dis 2004; 23:456-457.
26. Gross MD, Siegel EC. Incidence of mutator strains in Escherichia coli and coliforms in nature. Mutat Res 1981; 91:107-110.
27. Oliver A, Baquero F, Blazquez J. The mismatch repair system (mutS, mutL and uvrD genes) in Pseudomonas aeruginosa: molecular characterization of naturally occurring mutants. Mol Microbiol 2002; 43:1641-1650.
28. Oliver A, Sanchez JM, Blazquez J. The GO system of Pseudomonas aeruginosa. FEMS Microbiol Lett 2002; 217:31-35.
29. Baquero MR, Nilsson AI, Turrientes MC, Sandvang D, Galan JC, Martinez JL, et al. Polymorphic mutation frequencies in Escherichia coli: emergence of weak mutators in clinical isolates. J Bacteriol 2004; 186:5538-5542.
30. Denamur E, Lecointre G, Darlu P, Tenaillon O, Acquaviva C, Sayada C, et al. Evolutionary implications of the frequent horizontal transfer of mismatch repair genes. Cell 2000; 103:711-721.
31. Brown EW, LeClerc JE, Baoguang L, Payne WL, Cebula TA. Phylogenetic evidence for horizontal transfer of mutS alleles among naturally occurring Escherichia coli strains. J Bacteriol 2001; 183:1631-1644.
32. Govan JR, Deretic V. Microbial pathogenesis in cystic fibrosis: Mucoid Pseudomonas aeruginosa ana Burkholderia cepacia. Microbiol Rev 1996; 60:539-574.
33. Lyczak JB, Cannon CL, Pier CB. Lung infections associated with cystic fibrois. Clin Microbiol Rev 2002; 15:194-222.
34. Gibson RL, Burns JL, Rammsey BW. Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Respir Crit Care Med 2003; 168:918-951.
35. Hancock REW, Mutharis LM, Chan L, Darveau RP, Speert DP, Pier GB. Pseudomonas aeruginosa isolates from patients with cystic fibrosis: a class of serum-sensitive, nontypable strains deficient in lipopolichacaride O side chains. Infect Immun 1983; 42:170-177.
36. Taylor RFH, Warner M, George RC, Hodson ME, Pitt TL. Auxotrophic mutants of Pseudomonas aeruginosa: increased resistance to antipseudomonal antibiotics in cystic fibrosis. Med Microbiol Lett 1993; 2:25-32.
37. Mahemthiralingam E, Campbell ME, Speert DP. Nonmotility and phagocytic resistance of Pseudomonas aeruginosa isolates from chronically colonized patients with cystic fibrosis. Infect Immun 1994; 62:596-605.
38. Haubler S, Tummler B, Weibroud H, Rohde M, Steinmetz I. Small-colony variants of Pseudomonas aeruginosa in cystic fibrosis. Clin Infect Dis 1999; 29:621-625.
39. Smania AM, Segura I, Pezza RJ, Becerra C, Albesa I, Argarana CE. Emergence of phenotypic variants upon mismatch repair disruption in Pseudomonas aeruginosa. Microbiology 2004; 150:1327-1338.
40. Picard B, Duriez P, Gouriou S, Matic I, Denamur E, Taddei F. Mutator natural Escherichia coli isolates have an unusual virulence phenotype. Infect immun 2001; 69:9-14.
41. Richardson AR, Yu Z, Popovic T, Stojiljkovic I. Mutator clones of Neisseria meningitidis in epidemic serogroup A disease. Proc Natl Acad Sci USA 2002; 99:6103-6107.
42. Denamur E, Bonacorsi S, Giraud A, Duriez P, Hilali F, Amorin C, et al. High frequency of mutator strains among human uropathogenic Escherichia coli isolates. J Bacteriol 2002; 184:605-609.
43. Martin P, Sun L, Hood DW, Moxon ER. Involvement of genes of genome maintenance in the regulation of phase variation frequencies in Neisseria meningitidis. Microbiology 2004; 150:3001-3012.
44. Bayliss CD, Sweetman WA, Moxon ER. Mutations in Haemophilus influenzae mismatch repair genes increase mutation rates of dinucleotide repeat tracts but not dinucleotide repeat-driven pilin phase variation rates. J Bacteriol 2004; 186:2928-2935.
45. Rad ME, Bifani P, Martín C, Kremer K, Samper S, Rauzier J, et al. Mutations in putative mutator genes of Mycobacterium tuberculosis strains of the W-Beijing family. Emerg Infect Dis 2003; 9:838-845.
46. Werngren J, Hoffner SE. Drug-susceptible Mycobacterium tuberculosis Beijing genotype does not develop mutationconferred resistance to rifampin at an elevated rate. J Clin Microbiol 2003; 41:1520-1 524.
47. Merino D, Réglier-Poupet, Berche P, Charbit A. The European Listeria Genome Consortium. A hypermutator phenotype attenuates the virulence of Listeria monocytogenes in a mouse model. Mol Microbiol 2002; 44:877-887.
48. Zahrt TC, Buchmeier N, Maloy S. Effect of mutS and recD mutations on Salmonella virulence. Infect immun 1999; 67:6168-6172.
49. Blazquez J. Hypermutation as a factor contributing to the acquisition of antimicrobial resistance. Clin Infect Dis 2003; 37:1201-1209.
50. Chopra I, O'Neill AJ, Miller K. The role of mutators in the emergence of antibiotic-resistant bacteria. Drug Resist Updat 2003; 6:137-145.
51. Henwood CJ, Livermore DM, James D, Warner M. and the Pseudomonas study group. Antimicrobial susceptibility of Pseudomonas aeruginosa: results of a UK survey and evaluation of the British society for antimicrobial chemotherapy disc susceptibility test. J Antimicrob Chemother 2001; 47:789-799.
52. Livermore DM. Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare? Clin Infect Dis 2002; 34:634-640.
53. Gutiérrez O, Juan C, Pérez JL, Oliver A. Lack of association between hypermutation and antibiotic resistance develop-ment in Pseudomonas aeruginosa isolates from intensive care unit patients. Antimicrob Agents Chemother 2004; 48:3573-3575.
54. Oliver A, Levin BR, Juan C, Baquero F, Blázquez J. Hypermutation and the pre-existence of antibiotic resistance Pseudomonas aeruginosa mutants: implications for susceptibility testing and treatment of chronic infections. Antimicrob Agents Chemother 2004; 48:4226-4233.
55. Macia MD, Borrell N, Perez JL, Oliver A. Detection and susceptibility testing of hypermutable Pseudomonas aeruginosa strains with the Etest and disk diffusion. Antimicrob Agents Chemother 2004; 48:2665-2672.
56. Schaaff F, Reipert A, Bierbaum G. An elevated mutation frequency favors development of vancomycin resistance in Staphylococcus aureus. Antimicrob Agents Chemother 2002; 46:3540-3548.
57. O'Neill AJ, Chopra I. Insertional inactivation of mutS in Staphylococcus aureus reveals potential for elevated mutation frequencies, although the prevalence of mutators in clinical isolates is low. J Antimicrob Chemother 2002; 50:161-169.
58. O'Neill A, Chopra I, Bierbaum G, Reipert A, Schaaff F. Lack of evidence for involvement of hypermutability in emergence of vancomycin-intermediate Staphylococcus aureus. Antimicrob Agents Chemother 2003; 47:1484-1485.
59. Giraud A, Matic I, Radman M, Fons M, Taddei F. Mutator bacteria as a risk factor in treatment of infectious diseases. Antimicrob Agents Chemother 2002; 46:863-865.
60. Lindgren PK, Karlsson A, Hughes D. Mutation rate and evolution of fluoroquinole resistance in Escherichia coli isolates from patients with urinary tract infections. Antimicrob Agents Chemother 2003; 47:3222-3232.
61. Luria S, Delbruck M. Mutations of bacteria from virus sensitivity to virus resistance. Genetics 1943; 28:491-511.
62. Crane GJ, Thomas SM, Jones ME. A modified Luria-Delbruck fluctuation assay for estimating and comparing mutation rates. Mutat Res 1996; 354:171-182.
63. Galán JC, Tato M, Baquero MR, Turrientes C, Baquero F, Martínez JL. Fosfomycin and rifampin disk diffusion test for detection of Escherichia coli mutator strains. J Clin Microbiol 2004; 42:4310-4312.